Description
Unlike other CNS tumors, meningiomas lack a unified molecular classification system despite recent advances in molecular biomarkers. This gap prevents standardized prognostication and treatment stratification across institutions and limits precision medicine approaches.
Gap type: open_question Source paper: Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients. (None, None, PMID:38695575)